Related references
Note: Only part of the references are listed.STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis
Yuqi Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Funda Meric-Bernstam et al.
CLINICAL CANCER RESEARCH (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui et al.
CELL (2021)
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
Baihao Zhang et al.
NATURE (2021)
Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy
Xiaoqi Sun et al.
NATURE NANOTECHNOLOGY (2021)
STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
Emily P. Vonderhaar et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Natural Killer Cells: From Innate to Adaptive Features
Adriana M. Mujal et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5
Lihi Radomir et al.
NATURE COMMUNICATIONS (2021)
Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function
Sam Sheppard et al.
CELL REPORTS (2021)
STING Agonists as Cancer Therapeutics
Afsaneh Amouzegar et al.
CANCERS (2021)
Non-apoptotic TRAIL function modulates NK cell activity during viral infection
Ludmila Cardoso Alves et al.
EMBO REPORTS (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
Bhalchandra Mirlekar et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
Zixi Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion
Jianjun Wu et al.
IMMUNITY (2020)
Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING
Sytse J. Piersma et al.
ELIFE (2020)
The Age of Cyclic Dinucleotide Vaccine Adjuvants
Himanshu Gogoi et al.
VACCINES (2020)
cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy
Wenwen Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
Henrique Lemos et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
An orally available non-nucleotide STING agonist with antitumor activity
Bo-Sheng Pan et al.
SCIENCE (2020)
TUBB1 dysfunction in inherited thrombocytopenia causes genome instability
Takayoshi Matsumura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
STING signalling protects against chronic pancreatitis by modulating Th17 response
Qinglan Zhao et al.
GUT (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Deepali Sawant et al.
NATURE IMMUNOLOGY (2019)
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Huayang Liu et al.
NATURE MEDICINE (2019)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Bhalchandra Mirlekar et al.
CANCER IMMUNOLOGY RESEARCH (2018)
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
Abdi Ghaffari et al.
BRITISH JOURNAL OF CANCER (2018)
B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen
Sheng Hong et al.
IMMUNITY (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Ning Cheng et al.
JCI INSIGHT (2018)
EBI3 regulates the NK cell response to mouse cytomegalovirus infection
Helle Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
IL-6/IL-12 Cytokine Receptor Shuffling of Extra-and Intracellular Domains Reveals Canonical STAT Activation via Synthetic IL-35 and IL-39 Signaling
D. M. Floss et al.
SCIENTIFIC REPORTS (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER DISCOVERY (2016)
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
Rebecca A. Evans et al.
JCI INSIGHT (2016)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Antoine Marais et al.
NATURE IMMUNOLOGY (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
The critical role of IL-15-PI3K-mTOR pathway in natural killer cell effector functions
Neethi Nandagopal et al.
FRONTIERS IN IMMUNOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
Fabian Flores-Borja et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
DEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Likun Wang et al.
BIOINFORMATICS (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
Stability of the Regulatory T Cell Lineage in Vivo
Yuri P. Rubtsov et al.
SCIENCE (2010)
Reaulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces
Yuri P. Rubtsov et al.
IMMUNITY (2008)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Joel D. Nelson et al.
NATURE PROTOCOLS (2006)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation
A Mizoguchi et al.
IMMUNITY (2002)
Share Paper
